About
Ken Macnamara is the CEO of Trogenix. He previously worked at Asklepios BioPharmaceutical as a Chief Product Officer. Ken Macnamara attended the University of Edinburgh.
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Ken Macnamara is one of them.
- • 173 investors are based in Edinburgh, Edinburgh, City of, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Edinburgh, UK
Contact Information
linkedin.com/in/••••••••
Find more investors like Ken
Search Investors